Case Report
Published on 08 Oct 2025
Case report: Anlotinib plus oral etoposide: a potential salvage therapy based on insights from EGFR-TKI-resistant SCLC transformation PDX and clinical settings
in Thoracic Oncology
- 548 views
Case Report
Published on 08 Oct 2025
in Thoracic Oncology
Original Research
Published on 08 Oct 2025
in Addictive Disorders
Original Research
Published on 08 Oct 2025
in Neuro-Oncology and Neurosurgical Oncology
Correction
Published on 08 Oct 2025
in Pediatric Infectious Diseases
Case Report
Published on 08 Oct 2025
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Original Research
Published on 08 Oct 2025
in Nutrition and Sustainable Diets
Review
Published on 08 Oct 2025
in T Cell Biology
Original Research
Published on 08 Oct 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 08 Oct 2025
in Orthopedic Surgery
Original Research
Published on 08 Oct 2025
in Pediatric Pulmonology
Case Report
Published on 08 Oct 2025
in Genitourinary Oncology
Original Research
Published on 08 Oct 2025
in Robot Learning and Evolution
Original Research
Published on 08 Oct 2025
in Pharmacoepidemiology
Original Research
Published on 08 Oct 2025
in Ophthalmology
Policy and Practice Reviews
Published on 08 Oct 2025
in Sports Politics, Policy and Law
Editorial
Published on 08 Oct 2025
in Signaling